Search
for
Sort by
Research 271–300 of 1000+
- Cellular Plasticity in Cutaneous Wound Healing
- Synergistic therapeutic effect of systemic steroids and dithranol in a patient of alopecia totalis—A case report
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Adenovirus-Mediated Wnt10b Overexpression Induces Hair Follicle Regeneration
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- Role of stem/progenitor cells in reparative disorders
- Topical Valproate Solution for Hair Growth
- A Review on Drug Induced Alopecia
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- Design and development of Epigallocatechin gallate and Fenugreek seed extract loaded Nanosponge based Aloevera gel for treating Alopecia Areata
- COVID-19 infection leading to acute pustular dermatoses
- Hypothesis: Wound‐induced TLR3 activation stimulates endogenous retinoic acid synthesis and signalling during regeneration
- Cytokines
- Inflammasome Proteins as Biomarkers of Injury and Disease
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- 1. Medical Practice; Therapy; Adverse Reactions
- 12. Cancer
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Drug Reactions Affecting Hair: Diagnosis
- Drug-Induced Hair Disorders
- Skin disease in pregnancy
- Regulatory T cells are required for normal and activin‐promoted wound repair in mice
- Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Insulin resistance is increased in alopecia areata patients
- Long COVID syndrome: An unfolding enigma
- The developing immune network in human prenatal skin
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus